All News #Library
Biotech
Agendia: NCCN Recognizes MammaPrint for HR+/HER2- Breast Cancer
20 Jan 2026 //
BUSINESSWIRE
Agendia Spotlights MammaPrint, BluePrint to Guide Anthracycline
25 Nov 2025 //
BUSINESSWIRE
Agendia Named 2025 Best Genomics Company by MedTech Breakthrough
08 May 2025 //
GLOBENEWSWIRE
Agendia Presents New Genomic Testing Data at Breast Surgeons Meet
24 Apr 2025 //
BUSINESSWIRE
Agendia to Present New Findings on Early-Stage Breast Cancer at SABCS
25 Nov 2024 //
BUSINESSWIRE

Market Place
Sourcing Support